БЛОГ

Dec 2, 2024

New study explores obecabtagene autoleucel for adults with hard-to-treat leukemia

Posted by in category: futurism

FELIX study results reveal obe-cel’s potential in relapsed B-cell ALL, achieving 77% remission with low severe toxicity, enhancing CAR T-cell therapy outcomes.

Leave a reply